West Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Buy
361
+84
+30% +$85.8K 0.07% 93
2026
Q1
$256K Buy
277
+17
+7% +$17.2K 0.05% 110
2025
Q4
$280K Sell
260
-10
-4% -$9.56K 0.06% 99
2025
Q3
$223K Buy
+270
New +$201K 0.05% 117

Other funds holding LLY

West Wealth Group's LLY Position: Q2 2026 in Review

West Wealth Group increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $85.8K and bringing the position to 361 shares worth $433K. The position accounts for 0.07% of the portfolio, ranked #93.

West Wealth Group first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • West Wealth Group held 361 shares of Eli Lilly worth $433K as of Q2 2026.
  • West Wealth Group bought 84 Eli Lilly shares in Q2 2026, an estimated $85.8K.
  • Eli Lilly made up 0.07% of West Wealth Group's portfolio in Q2 2026, its #93 holding.
  • West Wealth Group first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on West Wealth Group's 13F filing for Q2 2026, filed 6 Aug 2026.